Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 171,415 | reported | 01 Mar 2022 | tx 10+418,362−761 |
| ImageneBio, Inc. | 85,400 | reported | 16 Mar 2026 | tx 4+827,520 |
| Poseida Therapeutics, Inc. | 0 | reported | 08 Jan 2025 | tx 7+1,450,361−1,459,361 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | GRANT_AWARD | ImageneBio, Inc. | 85,400 | 0.00 USD | |
| 16 Mar 2026 | GRANT_AWARD | ImageneBio, Inc. | 128,100 | 0.00 USD | deriv |
| 28 Jul 2025 | GRANT_AWARD | ImageneBio, Inc. | 153,505 | 0.00 USD | deriv |
| 28 Jul 2025 | GRANT_AWARD | ImageneBio, Inc. | 460,515 | 0.00 USD | deriv |
| 08 Jan 2025 | TENDER | Poseida Therapeutics, Inc. | 615,836 | — | |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 345,200 | 0.00 USD | deriv |
| 08 Jan 2025 | OTHER | Poseida Therapeutics, Inc. | 498,325 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 250,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Poseida Therapeutics, Inc. | 345,200 | 0.00 USD | deriv |
| 11 Apr 2023 | GRANT_AWARD | Poseida Therapeutics, Inc. | 356,836 | 0.00 USD | |
| 11 Apr 2023 | GRANT_AWARD | Poseida Therapeutics, Inc. | 498,325 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 45,533 | 0.00 USD | |
| 01 Mar 2022 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 85,592 | 0.00 USD | deriv |
| 14 Jun 2021 | PURCHASE | Atara Biotherapeutics, Inc. | 28,833 | 14.58 USD | |
| 14 Jun 2021 | PURCHASE | Atara Biotherapeutics, Inc. | 3,500 | 14.48 USD | |
| 11 Jun 2021 | PURCHASE | Atara Biotherapeutics, Inc. | 2,021 | 14.50 USD | |
| 18 May 2021 | SALE | Atara Biotherapeutics, Inc. | 761 | 14.55 USD | |
| 01 Mar 2021 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 35,021 | 0.00 USD | |
| 01 Mar 2021 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 52,862 | 0.00 USD | deriv |
| 01 Mar 2020 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 55,000 | 0.00 USD | |
| 18 Feb 2020 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 110,000 | 0.00 USD | deriv |